# Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

> **NCT05713760** · PHASE2 · COMPLETED · sponsor: **Austin Institute for Clinical Research** · enrollment: 5 (actual)

## Conditions studied

- Superficial Basal Cell Carcinoma

## Interventions

- **DRUG:** Tirbanibulin Ointment 1%

## Key facts

- **NCT ID:** NCT05713760
- **Lead sponsor:** Austin Institute for Clinical Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-17
- **Primary completion:** 2024-03-07
- **Final completion:** 2024-03-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05713760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05713760, "Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05713760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*